The purpose of this Mentored Clinical Scientist Development Award application is to provide me with the necessary training to develop into an independent investigator of tumor biology. My career goal is to investigate the mechanisms of tumor cell invasion in tumors of the head and neck, and to apply those discoveries to the development of novel therapies designed to inhibit local and distant tumor cell extravasation. The underlying hypothesis of this Mentored Award is that tumor-stromal interactions create a tumor microenvironment that facilitates tumor cell invasion. This application proposes to investigate the role of extracellular matrix metalloproteinase inducer (EMMPRIN) in head and neck squamous cell carcinoma (HNSCC) as a paradigm for understanding the role of tumor-stromal interactions in tumor cell invasion. We hypothesize that tumor-stromal interactions promote HNSCC tumor cell invasion and, specifically that cell surface EMMPRIN expression promotes local tumor cell invasion in tumors of the head and neck by inducing the expression of matrix metalloproteases (MMPs). Recently it has been shown that carcinoma associated fibroblasts undergo distinct cellular alterations compared to normal fibroblasts and secrete most of the peritumoral MMPs. We therefore propose to: 1) localize EMMPRIN and MMP expression in human HNSCC tumors, 2) assess MMP expression in normal and carcinoma associated fibroblasts stimulated by EMMPRIN, 3) determine the in vitro and in vivo phenotype of EMMPRIN upregulation in tumor cell lines, and 4) identify other candidate genes in carcinoma associated fibroblasts that may be important in tumor-stromal interactions. ? ? The mentors on this training proposal are international experts in tumor biology and tumor cell invasion. The program is fully endorsed by the Division of Otolaryngology and Department of Surgery, which will provide the necessary resources. I intend to devote my career to: 1) investigating the proteolytic mechanisms of tumor cell invasion and metastasis, 2) understanding the role of the tumor microenvironment in promoting tumor cell growth and metastasis, and 3) bringing new therapies directed at arresting tumor cell invasion into clinical use. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08CA102154-02
Application #
7062492
Study Section
Subcommittee G - Education (NCI)
Program Officer
Eckstein, David J
Project Start
2005-05-09
Project End
2010-04-30
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
2
Fiscal Year
2006
Total Cost
$92,407
Indirect Cost
Name
University of Alabama Birmingham
Department
Surgery
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Knowles, Joseph A; Heath, Cara H; Saini, Reshu et al. (2012) Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 138:662-8
Shah, Nemil; Zhai, Guihua; Knowles, Joseph A et al. (2012) (18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts. Mol Imaging Biol 14:237-44
Sweeny, Larissa; Zimmermann, Terence M; Liu, Zhiyong et al. (2012) Evaluation of tyrosine receptor kinases in the interactions of head and neck squamous cell carcinoma cells and fibroblasts. Oral Oncol 48:1242-9
Kim, Hyunki; Zhai, Guihua; Liu, Zhiyong et al. (2011) Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy. Anticancer Drugs 22:864-74
Knowles, Joseph A; Golden, Blake; Yan, Li et al. (2011) Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinoma. Laryngoscope 121:2359-65
Liu, Zhiyong; Hartman, Yolanda E; Warram, Jason M et al. (2011) Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells. Mol Cancer Res 9:1008-17
Helman, Emily E; Newman, J Robert; Dean, Nichole R et al. (2010) Optical imaging predicts tumor response to anti-EGFR therapy. Cancer Biol Ther 10:166-71
Dean, Nichole R; White, Hilliary N; Carter, Dale S et al. (2010) Outcomes following temporal bone resection. Laryngoscope 120:1516-22
Dean, Nichole Renae; Knowles, Joseph A; Helman, Emily E et al. (2010) Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model. Anticancer Drugs 21:861-7
Dean, Nichole; Helman, Emily; Aldridge, Joszi et al. (2010) Anti-EMMPRIN treatment of HNSCC in an ex vivo model. Laryngoscope 120 Suppl 4:S146

Showing the most recent 10 out of 17 publications